News

Redburn Atlantic turned bullish on Charles River Laboratories International, Inc. (NYSE:CRL) as it upgraded its stock from ...
If European customers start to view Rocket Lab as a local company, it might start winning launch contracts from Europe. And ...
Rocket Lab remains a top growth stock pick, with strong Q1 results, robust launch demand, and a growing backlog. Read the ...
Rocket Lab will continue to benefit from its NSSL Phase 3 contract and Mynaric acquisition. Read more on this company's growing position in defense and commercial space markets.
Charles River Laboratories stock surged 16% Wednesday morning as the medical testing company made changes to its board and announced a strategic review as it faced pressure from Elliott Investment ...
U.S. equities were little changed at midday with the market focused on comments from the Federal Reserve coming later today.
Voya Investment Management LLC’s holdings in Bio-Rad Laboratories were worth $755,000 ... 29,144 shares of the medical research company’s stock worth $9,575,000 after acquiring an additional ...
While Rocket Lab specializes in providing end-to-end space solutions, including reliable launch services, spacecraft, satellite components and on-orbit management, Planet Labs, on the other hand ...